Study Atlas
Study accountPrivacySaved locally

Surgery

Carcinoid tumor

Follow the tumor’s secretions. Local effects come from the lesion itself, while systemic symptoms depend on where mediators enter the bloodstream.

High Yield20 min lesson estimate16 question families

Covered only in other uploaded question sources · 0 main-bank entries · 22 linked PDF entries · 4 generated drills

Prerequisites and related lessons
  • Tumors of the stomach
  • Irritable bowel syndrome (IBS)

Curriculum reference · Official College Textbook – Digestive Disorders – Part 1, pp. 131–132. Lesson adapted from Upper GIT surgery.

Topic map

  • Originenterochromaffin cells
  • Localappendiceal incidental tumor or ileal obstruction
  • Systemicflush, diarrhea, wheeze, valve disease
  • Work-upsecretion, receptors, tissue and stage
Portal clearance and bypass The liver usually clears portal serotonin. Hepatic metastases and some extra-portal primaries release mediators systemically.Gut NETLiver filterSystemic bloodLiver metastasisBronchial NETSystemic mediators bypass clearance
Portal clearance and bypassThe liver usually clears portal serotonin. Hepatic metastases and some extra-portal primaries release mediators systemically.

Definition, sites and mechanism

Carcinoid is the older term for a well-differentiated neuroendocrine tumor (NET) here. For serotonin-secreting intestinal tumors, the course names enterochromaffin (argentaffin) cells of the crypts of Lieberkühn. These cells respond to signals and release mediators. Use mitoses and Ki-67, a marker of proliferation, to grade well-differentiated NET, and distinguish poorly differentiated neuroendocrine carcinoma.

The course and exam list appendix [Surgery Mid Q1 · Old p. 61], followed by ileum and rectum, with stomach, bronchus and gonads as other sites. Frequency varies by registry and inclusion of incidental lesions. The course keys adenocarcinoma [Surgery Mid Q6] for most common primary malignant small-bowel tumor. This asks for a tumor class, distinct from the commonest carcinoid site.

Clinical picture and complications

Appendiceal NET is commonly incidental at appendectomy for suspected acute appendicitis. Ileal NET can cause colic, mechanical obstruction or mesenteric ischemia from desmoplasia, which is scar tissue around the tumor and feeding vessels. Jejunal obstruction [Surgery Mid Q3 · Old p. 82] is the EXCEPT option for the hormone syndrome despite local obstruction being possible with a bowel primary.

Carcinoid syndrome [Surgery Mid Q3/Q5 · Old pp. 70, 82, 95] includes episodic flushing [Old p. 95], diarrhea, abdominal colic, bronchospasm [Surgery Mid Q3 · Old p. 82], hepatomegaly with liver involvement and tricuspid or pulmonary valve dysfunction [Surgery Mid Q3 · Old pp. 82, 116]. Right-sided endocardial fibrosis can cause tricuspid regurgitation, pulmonary stenosis and right heart failure. Constipation is an EXCEPT answer. Book I gives an approximate syndrome frequency of 10%. Carcinoid crisis is acute instability with flushing, bronchospasm or major hemodynamic changes, sometimes associated with anesthesia or tumor manipulation.

The portal circulation normally delivers intestinal tumor secretions to the liver for metabolism. Liver metastasis [Surgery Mid Q4 · Old p. 116] can release mediators directly into hepatic venous blood. An ileal primary [Surgery Mid Q5] is a classic GI cause when metastatic. A bronchial primary [Old p. 70] or some gonadal NETs can bypass the portal circulation and cause syndrome without hepatic metastases. Redirecting tryptophan to serotonin can also contribute to niacin deficiency.

Investigations

Initial assessment
5-HIAA for suspected serotonin excess
Confirmation or staging
Histology classifies the tumor. Imaging determines stage.

24-hour urinary 5-HIAA [Surgery Mid Q2 · Old p. 71] measures a serotonin breakdown product. Book I uses normal <10 mg/day and >50 mg/day as a highly elevated course value. Interpretation depends on assay, food and drug interference and proper collection. A nonsecreting lesion can have normal 5-HIAA. VMA is a catecholamine metabolite, and stool sampling does not measure the course's answer.

Contrast CT/MRI maps mesentery, nodes and liver. Somatostatin receptor PET can stage receptor-positive disease and guide receptor-directed therapy. Histology with markers such as synaptophysin/chromogranin and proliferation index classifies the lesion. Image-guided tissue from a liver lesion can confirm metastasis. Echocardiography evaluates suspected carcinoid heart disease. Chromogranin A can be confounded by acid suppression and other conditions.

Management

The textbook uses appendectomy for a small tip lesion and right hemicolectomy with resection of the solitary liver metastasis [Surgery Mid Q4] for the exam's base lesion with an operable liver focus. Current decisions consider size, grade, margin, invasion and stage. Appendectomy often suffices for small low-risk fully excised tumors. Location at the base alone does not determine whether to perform completion colectomy.

Resect localized intestinal NET and appropriate mesenteric disease when feasible, preserving blood supply. Liver resection, debulking or liver-directed therapy are options for selected metastatic disease. Octreotide or lanreotide controls secretion and can slow progression. Progressive receptor-positive disease may qualify for peptide receptor radionuclide therapy, which carries radiation to tumor cells through their receptors. Coordinate heart disease, crisis risk and additional systemic options with the specialist team.

Exam traps

Urinary 5-HIAA tests for serotonin secretion. Tissue establishes the diagnosis and grade. The carcinoid hormone syndrome includes diarrhea, flushing, wheezing and right-sided valve problems. The Old and Surgery Mid papers key different primaries for a stem that omits metastatic status.

Diagnostic and management pathways

  • Incidental appendiceal lesionsize, grade, margins and invasiondecide on staging and additional surgery
  • Flushing and secretory diarrheaassess 5-HIAA and alternativesimage and confirm histology
  • Localized diseasesite-specific surgery assessment
  • Metastatic or functional diseasesymptom control, heart assessment and multidisciplinary treatment

Compare at a glance

ScenarioClueImplication
Appendiceal NETFound at appendectomyRisk profile guides further treatment
Ileal NETObstruction or mesenteric fibrosisHepatic metastases can permit systemic syndrome
Bronchial NETRespiratory findings or functional symptomsCan bypass portal first-pass metabolism
Other causes of flushingIsolated flushing or different triggersAssess other causes alongside clinical and biochemical findings

Supplementary clarification – not directly stated in the uploaded materials. Clinical references · NCI gastrointestinal neuroendocrine tumor treatment

Exam words

  • appendix [Surgery Mid Q1 · Old p. 61]
  • adenocarcinoma [Surgery Mid Q6]
  • Jejunal obstruction [Surgery Mid Q3 · Old p. 82]
  • Carcinoid syndrome [Surgery Mid Q3/Q5 · Old pp. 70, 82, 95]
  • flushing [Old p. 95]
  • bronchospasm [Surgery Mid Q3 · Old p. 82]
  • tricuspid or pulmonary valve dysfunction [Surgery Mid Q3 · Old pp. 82, 116]
  • Liver metastasis [Surgery Mid Q4 · Old p. 116]
  • ileal primary [Surgery Mid Q5]
  • bronchial primary [Old p. 70]
  • 24-hour urinary 5-HIAA [Surgery Mid Q2 · Old p. 71]
  • right hemicolectomy with resection of the solitary liver metastasis [Surgery Mid Q4]

Practice questions

Rapid revision sheet

Sixty-second recall. Say the definition, the key clue and the next clinical step out loud before checking the list.

  • appendix [Surgery Mid Q1 · Old p. 61]
  • adenocarcinoma [Surgery Mid Q6]
  • Jejunal obstruction [Surgery Mid Q3 · Old p. 82]
  • Carcinoid syndrome [Surgery Mid Q3/Q5 · Old pp. 70, 82, 95]
  • flushing [Old p. 95]
  • bronchospasm [Surgery Mid Q3 · Old p. 82]

Official College Textbook – Digestive Disorders – Part 1, pp. 131–132

Active recall

Why does carcinoid syndrome in a midgut tumor often appear after liver metastases?

The liver normally metabolizes mediators arriving in the portal vein. Hepatic metastases can release them into the systemic circulation.

Official College Textbook – Digestive Disorders – Part 1, pp. 131–132

Recall the diagnostic and management pathway from memory.

Start with the presenting clue, name the first assessment, then distinguish confirmation, immediate management and follow-up.

  • Incidental appendiceal lesionsize, grade, margins and invasiondecide on staging and additional surgery
  • Flushing and secretory diarrheaassess 5-HIAA and alternativesimage and confirm histology
  • Localized diseasesite-specific surgery assessment
  • Metastatic or functional diseasesymptom control, heart assessment and multidisciplinary treatment
↑